These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 28069606)
21. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760 [TBL] [Abstract][Full Text] [Related]
22. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics. Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086 [TBL] [Abstract][Full Text] [Related]
23. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma. Wuillemin WA; Furlan M; Stricker H; Lämmle B Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242 [TBL] [Abstract][Full Text] [Related]
24. Titanium is a potent inducer of contact activation: implications for intravascular devices. Litvak M; Shamanaev A; Zalawadiya S; Matafonov A; Kobrin A; Feener EP; Wallisch M; Tucker EI; McCarty OJT; Gailani D J Thromb Haemost; 2023 May; 21(5):1200-1213. PubMed ID: 36696212 [TBL] [Abstract][Full Text] [Related]
25. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition. Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950 [TBL] [Abstract][Full Text] [Related]
35. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149 [TBL] [Abstract][Full Text] [Related]
36. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition. Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109 [TBL] [Abstract][Full Text] [Related]
37. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains. Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137 [TBL] [Abstract][Full Text] [Related]
38. Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI. Kearney KJ; Butler J; Posada OM; Wilson C; Heal S; Ali M; Hardy L; Ahnström J; Gailani D; Foster R; Hethershaw E; Longstaff C; Philippou H Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397811 [TBL] [Abstract][Full Text] [Related]
39. Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity. Mitchell JL; Lionikiene AS; Georgiev G; Klemmer A; Brain C; Kim PY; Mutch NJ Blood; 2016 Dec; 128(24):2834-2845. PubMed ID: 27694320 [TBL] [Abstract][Full Text] [Related]